AU2003225623A1 - Ku-70-derived bax-suppressing peptides and use thereof for the protection of damaged cells - Google Patents

Ku-70-derived bax-suppressing peptides and use thereof for the protection of damaged cells

Info

Publication number
AU2003225623A1
AU2003225623A1 AU2003225623A AU2003225623A AU2003225623A1 AU 2003225623 A1 AU2003225623 A1 AU 2003225623A1 AU 2003225623 A AU2003225623 A AU 2003225623A AU 2003225623 A AU2003225623 A AU 2003225623A AU 2003225623 A1 AU2003225623 A1 AU 2003225623A1
Authority
AU
Australia
Prior art keywords
protection
damaged cells
bax
derived
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003225623A
Other versions
AU2003225623A8 (en
Inventor
Shigemi Matsuyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Blood Center Research Foundation Inc
Original Assignee
Blood Center Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blood Center Research Foundation Inc filed Critical Blood Center Research Foundation Inc
Publication of AU2003225623A8 publication Critical patent/AU2003225623A8/en
Publication of AU2003225623A1 publication Critical patent/AU2003225623A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
AU2003225623A 2002-03-01 2003-02-28 Ku-70-derived bax-suppressing peptides and use thereof for the protection of damaged cells Abandoned AU2003225623A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US36075502P 2002-03-01 2002-03-01
US60/360,755 2002-03-01
US38420402P 2002-05-30 2002-05-30
US60/384,204 2002-05-30
PCT/US2003/006270 WO2003074667A2 (en) 2002-03-01 2003-02-28 Ku-70-derived bax-suppressing peptides and use thereof for the protection of damaged cells

Publications (2)

Publication Number Publication Date
AU2003225623A8 AU2003225623A8 (en) 2003-09-16
AU2003225623A1 true AU2003225623A1 (en) 2003-09-16

Family

ID=27791652

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003225623A Abandoned AU2003225623A1 (en) 2002-03-01 2003-02-28 Ku-70-derived bax-suppressing peptides and use thereof for the protection of damaged cells

Country Status (5)

Country Link
US (1) US7314866B2 (en)
EP (1) EP1487268A4 (en)
JP (1) JP2006501812A (en)
AU (1) AU2003225623A1 (en)
WO (1) WO2003074667A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006501812A (en) * 2002-03-01 2006-01-19 ブラッド センター リサーチ フオンデーシヨン BAX inhibitory peptides derived from KU-70 and their use to protect damaged cells
US20080103101A1 (en) * 2003-02-28 2008-05-01 Shigemi Matsuyama Ku-70-derived bax-suppressing peptides and use thereof for the protection of damaged cells
US9458427B2 (en) * 2009-08-07 2016-10-04 Case Western Reserve University IFNγR2 compositions and methods of inhibiting neuronal cell death
US8324170B2 (en) * 2009-08-07 2012-12-04 Case Western Reserve University Interferon gamma receptor beta chain compositions and methods of inhibiting apoptosis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5063637A (en) * 1989-03-17 1991-11-12 Howard Jr Daggett H Laminated article with hinge and method for manufacturing laminated articles
US5770690A (en) * 1995-06-27 1998-06-23 Neurex Corporation Bax omega protein and methods
US5837838A (en) * 1997-03-14 1998-11-17 The Burnham Institute Bax inhibitor proteins
ATE458050T1 (en) * 1998-12-01 2010-03-15 Genentech Inc PROMOTION OR INHIBITION OF ANGIOGENESIS AND CARDIOVASCULARIZATION
US6422875B1 (en) * 1999-01-19 2002-07-23 Lance Patak Device for communicating with a voice-disabled patient
GB9907687D0 (en) * 1999-04-01 1999-05-26 Kudos Pharm Ltd Assays methods and means
EP1125925A1 (en) * 2000-02-15 2001-08-22 Applied Research Systems ARS Holding N.V. Amine derivatives for the treatment of apoptosis
AU2002326980A1 (en) * 2001-09-24 2003-04-07 Blood Center Research Foundation Method of modulating or examining ku70 levels in cells
JP2006501812A (en) * 2002-03-01 2006-01-19 ブラッド センター リサーチ フオンデーシヨン BAX inhibitory peptides derived from KU-70 and their use to protect damaged cells

Also Published As

Publication number Publication date
US20030216323A1 (en) 2003-11-20
WO2003074667A3 (en) 2004-01-15
EP1487268A2 (en) 2004-12-22
EP1487268A4 (en) 2005-08-24
AU2003225623A8 (en) 2003-09-16
WO2003074667A2 (en) 2003-09-12
US7314866B2 (en) 2008-01-01
JP2006501812A (en) 2006-01-19

Similar Documents

Publication Publication Date Title
AU2003239159A1 (en) Placental derived stem cells and uses thereof
AU2003254950A1 (en) Peptides and drugs containing the same
AU2003215399A1 (en) Reactive-adsorptive protective materials and methods for use
AU2003299528A1 (en) Gas storage materials and devices
AU2003267124A1 (en) Bh3 peptides and method of use thereof
EP1519431A4 (en) Electrode and cell comprising the same
AU2003281736A1 (en) Electrodes and related devices
AU2003254844A1 (en) Substituted amino compounds and use thereof
AU2003289228A1 (en) Material for fuel-system part and fuel-system part comprising the same
AU2003207744A1 (en) Transport peptides and uses therefor
AU2003292720A1 (en) Dihydrothienoquinoline derivatives and cell adhesion inhibitors containing the same
AU2003272423A1 (en) Centrosome proteins and uses thereof
AU2003281691A1 (en) Furoisoquinoline derivative and use thereof
AU2003225623A1 (en) Ku-70-derived bax-suppressing peptides and use thereof for the protection of damaged cells
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AU2003254902A1 (en) Myocardial cell protecting agents
AU2003302173A1 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
AU2003218232A1 (en) Peptide analogues and uses thereof
AU2003236096A1 (en) Peptide chemically modified with polyethylene glycol
AU2003291426A1 (en) Gp64-pseudotyped vectors and uses thereof
AU2003280992A1 (en) Novel proteins and use thereof
AU2003292774A1 (en) Novel proteins and use thereof
AU2003216712A1 (en) Means for the storage of cells and uses thereof
AU2002951912A0 (en) Tryptase polypeptide and uses thereof
AU2002235019A1 (en) Novel pseudoceramides and cosmetic compositions comprising the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase